EnWave Senior Vice President Brent Charleton Calls Pharmaceutical Business “The Dark Horse In Our Investment Case”
Although our previous interview was conducted only a few months ago, the progress at EnWave Corp. (TSXV:ENW – $0.84 CAD & OTC:NWVCF – $0.66 USD) since, is very impressive. So we’re very pleased that Mr. Brent Charleton, the Vice President Business Development, freed up some time to give us an update on the Company.
Mr. Charleton is enthusiastic about EnWave’s financials in light of additional commercial licenses and machine purchase orders that were recently signed.
The continued success of Moon Cheese at Starbucks receives plenty of attention and Mr. Charleton describes potential deals for the cheese snack. He also discusses the excellent progress at both Milne Fruits and Hormel Foods and their possible need for more REV machinery.
The interview also takes a look at Bonduelle, which recently launched REV dried frozen vegetables under the brand InFlavor. Mr. Charleton touches upon the global leader’s expansion plans in Europe for this new category of dehydrofrozen foods.
The Vice President explains the tremendous potential for the Company’s pharmaceutical business in the short-term. He even describes it as “the dark horse in our investment case”. And he also gives us a clear picture of the number of expected machine orders in the coming quarters.
All in all, this interview is helpful to discover this interesting Company or to brush up on your knowledge of the firm.
Access our interview by clicking the play button on the media player below,
or download our convenient transcript.
| || |
|For important disclosures, please read our disclaimer.||Latest Company Report (pdf)|